According to the angiogenesis experiment, miR-2052 inhibitor partially restored the effects of si-LINC01857, while si-CENPQ partially rescued the effects of the miR-2052 inhibitor on the angiogenesis abilities of BC cells (Figure 5a). This evidence concerns the gene LINC01857 and breast cancer.